A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential
Elisa Uliassi(University of Bologna), María Laura Bolognesi(University of Bologna), Michele Rossi(University of Bologna), Emiliano Peña‐Altamira(University of Bologna), Loreto Martínez‐González(Consejo Superior de Investigaciones Científicas), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Aixa V. Morales(Instituto Cajal), Sabrina Petralla(Heidelberg University), Francesca Massenzio(Babraham Institute), Barbara Monti(University of Bologna), Marinella Roberti(University of Bologna)
Cited by 21
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
|Brain Behavior and Immunity|2018|293